Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
This study has been completed.
Study NCT00106561 Information provided by Melbourne Health
First Received: March 25, 2005 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease
Diabetic Nephropathy
Glomerulonephritis
Proteinuria
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Nephritis
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Spironolactone
Irbesartan
Additional drug interventions recognized in this trial
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
More general drug interventions related to this trial
Aldosterone Antagonists
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Melbourne Health
Back to top of Main Content
